Combination antihypertensive therapy, particularly fixed-dose combinations, simplifies treatment regimens and may improve poor patient compliance.
Answers are grounded in this paper and cite their sources.
May support fixed-dose combinations to improve adherence in hypertension; leaves open need for outcome trials.
Both in clinical practice and in drug trials, combination treatment of hypertension plays a fundamental role. This article reviews the features that make combined therapy with two drugs valuable, i.e., additive antihypertensive efficacy, different mechanisms of action, and reciprocal side-effect minimization. Also examined are the advantages and disadvantages of a fixed combination, emphasizing that a major advantage is simplification of the treatment schedule. This is clinically relevant because complexity of treatment negatively affects patient compliance, which in hypertensive patients is poor, leading to poor long-term blood pressure control in the hypertensive fraction of the population.
No takes yet. Share an insight, caveat, or question.
Mancia et al. (1998) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: